763

TGF β Receptor II Polyclonal Antibody | E-AB-40049

(No reviews yet) Write a Review
SKU:
763-763-E-AB-40049-GEN
NULL401.00 - NULL553.00

Description

TGF β Receptor II Polyclonal Antibody | E-AB-40049 | Gentaur UK, US & Europe Distribution

Type: Polyclonal Antibody

Synonyms: AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2, RIIC, TAAD2, TbetaR II, TbetaR-II, TGF beta receptor type 2, TGF beta receptor type II, TGF beta receptor type IIB, TGF beta type II receptor, TGF-beta receptor type II, TGF-beta receptor type-2, TGF-beta type II receptor, TGF-beta-R2, TGFB R2, TGFbeta - RII, TGFbeta RII, Tgfbr2, TGFR-2, TGFR2, Transforming growth factor beta receptor II, Transforming growth factor beta receptor type II, Transforming growth factor beta receptor type IIC, Transforming growth factor, beta receptor II (70/80kDa), transforming growth factor, beta receptor II alpha, transforming growth factor, beta receptor II beta, transforming growth factor, beta receptor II delta, transforming growth factor, beta receptor II epsilon, transforming growth factor, beta receptor II gamma, Transforming growth factor-beta receptor type II

Application: IHC

Reactivity: Human, Mouse

Host: Rabbit

Isotype: IgG

Reserch Areas: Cancer, Signaling transduction, Stem cells

Background: Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways.

Concentration: 2 mg/mL

Storage: Store at -20°C. Avoid freeze / thaw cycles.

Immunogen: Recombinant human TGF-beta receptor type-2 protein

Buffer: PBS with 0.02% sodium azide and 50% glycerol pH 7.4.

Purification Method: Affinity purification

Dilution: IHC 1:50-1:100

Clone: N/A

Conjugation: Unconjugated

Molecular Weight(Calculated): N/A

Molecular Weight(Observed): N/A

View AllClose